🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Texas

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Texas

15 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • Texas Oncology-Austin Central ( Site 0107), Austin
  • Urology Austin, PLLC ( Site 0109), Austin
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

  • Urology Austin, Austin
  • Urology Clinics of North Texas, Dallas
  • Baylor College of Medicine, Houston
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

  • Texas Oncology-Austin, Austin
  • Urology Austin, Austin
  • Urology San Antonio PA dba USA Clinical Trials, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  • Cancer Center Outpatient Building, Dallas
  • The University of Texas Southwestern Medical Center, Dallas
  • UT Southwestern Medical Center - West Campus Building, Dallas
  • ak 5 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

  • UPNT Research Institute, Arlington
  • UT Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07309445

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

  • UT Southwestern Medical Center, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05796375

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Urology Partners of North Texas, Arlington
  • Urology Austin, LLC, Austin
  • Houston Metro Urology, Houston
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

  • University of Texas Southwestern Medical Center, Dallas
  • University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05825950

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • Urology Partners of North Texas, Arlington
  • Houston Metro Urology, Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Texas Southwestern, Dallas
  • Texas Oncology, P.A, Dallas
  • MD Anderson Cancer Center, Houston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

  • Natera, Inc., Austin
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07763197

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Urology Austin, Austin
  • UT Southwestern Medical Center, Dallas
  • Houston Metro Urology, Houston
  • ak 2 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

  • UT Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07673016

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  • University of Texas Southwestern Medical Center, Dallas
  • Urology Partners of North Texas, Fort Worth
  • Baylor College of Medicine, Houston
  • ak 2 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Blue Light Cystoscopy With Cysview® Registry

  • UT Southwestern, Dallas
  • Michael E. DeBakey VA Medical Center, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.